Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsVAGINALGeneric

TERRAMYCIN-POLYMYXIN

OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE

Standard Dose
EQ 100MG BASE;100,000 UNITS
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview TERRAMYCIN-POLYMYXIN is listed in Drugs@FDA under application 061009 (ANDA).

Marketing status: Discontinued Active ingredient OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE Form and strength TABLET;VAGINAL - EQ 100MG BASE;100,000 UNITS Sponsor PFIZER Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview TERRAMYCIN-POLYMYXIN is listed in Drugs@FDA under application 061009 (ANDA). Marketing status: Discontinued Active ingredient OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE Form and strength TABLET;VAGINAL - EQ 100MG BASE;100,000 UNITS Sponsor PFIZER Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
TERRAMYCIN-POLYMYXIN (OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE) | Drug Monograph | MedicHelpline